A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

Completed · Phase 1/Phase 2

Conditions studied: Non-infectious Anterior Uveitis

In brief

The objective of this study is to evaluate the safety of TRS01 eye drops in participants with active non-infectious anterior uveitis .

Key facts

Study ID

NCT04222712

Run by

Tarsier Pharma

People needed

16

Starts

2020-02-01

Expected to finish

2020-08-24

Last updated by the study team

2023-10-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Able to provide informed consent, follow instructions and complete all required study visits for the duration of the study.
• Diagnosed with active non-infectious anterior uveitis requiring an increase or initiation of topical steroids for management of ocular inflammation.
• An eligible subject must have:
• Non-infectious active anterior uveitis with anterior chamber cells Grade 2 or Grade 3, as specified per protocol.
• Must have vision ≥ 20/40 in the non-study eye.
• Use adequate birth control by men and women, if of reproductive potential and sexually active, as specified per protocol.

You may not qualify if…

• Any form of infectious uveitis
• Active retinitis
• Cancer or melanoma that is actively treated with immunotherapy
• Pregnancy / lactation
• Receiving specific medication/interventions as specified per protocol

Where it is running

• Palisades Park — Palisades Park, New Jersey, United States
• San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.